Filing Details
- Accession Number:
- 0001209191-17-044425
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-07 17:02:00
- Reporting Period:
- 2017-07-05
- Filing Date:
- 2017-07-07
- Accepted Time:
- 2017-07-07 17:02:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1642041 | Paul Trower | 1801 Augustine Cut-Off Wilmington DE 19803 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-05 | 1,198 | $0.00 | 12,148 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2017-07-05 | 3,000 | $17.79 | 15,148 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-05 | 3,000 | $126.18 | 12,148 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2017-07-05 | 2,539 | $0.00 | 2,539 | $128.34 |
| Common Stock | Incentive Stock Option (right to buy) | Acquisiton | 2017-07-05 | 216 | $0.00 | 216 | $128.34 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-07-05 | 3,000 | $0.00 | 3,000 | $17.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,539 | 2027-07-04 | No | 4 | A | Direct | |
| 216 | 2027-07-04 | No | 4 | A | Direct | |
| 25,187 | 2019-01-18 | No | 4 | M | Direct |
Footnotes
- Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Mr. Trower's continued service with the Issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Represents weighted average sale price. Actual sale prices ranged from $125.47 - $126.76.
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Includes an aggregate of 4,380 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Beginning July 5, 2017, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Billionaire Hedge Funds
